Acute Coronary Syndrome Evaluation and Management
Immediate Actions
- The American College of Cardiology recommends transporting the patient urgently to the emergency department, ideally by emergency medical services (EMS), rather than allowing self-transport, for a patient with chest pain and significant risk factors for life-threatening cardiac events 1
- Administer aspirin 250-500 mg (chewable or water-soluble) immediately if no contraindications exist, as recommended by the American Heart Association 1
- Place the patient on continuous cardiac monitoring with emergency resuscitation equipment and defibrillator readily available, as suggested by the European Society of Cardiology 1
- Obtain a 12-lead ECG within 10 minutes of arrival to identify ST-segment elevation myocardial infarction (STEMI), ST-segment depression, T-wave inversions, or new left bundle branch block, as recommended by the American Heart Association 2, 1
- Measure cardiac troponin as soon as possible after presentation, as recommended by the European Society of Cardiology 1
Risk Stratification Based on Initial Assessment
- The American College of Cardiology suggests that pain characteristics, such as retrosternal pressure, tightness, heaviness, or crushing sensation, can indicate acute coronary syndrome 3
- The American College of Cardiology recommends considering radiation pattern, such as pain radiating to neck, jaw, shoulders, back, or arms, to increase cardiac likelihood 3
- The American Heart Association suggests that associated symptoms, such as diaphoresis, nausea, vomiting, dyspnea, or lightheadedness, can significantly elevate risk 2
- The American College of Cardiology recommends considering precipitating factors, such as pain with exertion that resolves with rest, to suggest stable angina, while rest pain or accelerating symptoms indicate unstable angina/NSTEMI 3
ECG-Based Treatment Pathways
- The European Society of Cardiology recommends immediate reperfusion therapy (primary PCI or fibrinolysis) per STEMI protocols if ST-segment elevation is present 5
- The European Society of Cardiology suggests initiating medical therapy immediately while awaiting troponin results if ST-segment depression, T-wave inversions, or normal ECG is present 5, 2
- The European Society of Cardiology recommends aspirin 75-150 mg daily, clopidogrel loading dose, low molecular weight heparin (LMWH) or unfractionated heparin, and beta-blocker (e.g., metoprolol) unless contraindicated 5
Troponin-Based Risk Stratification
- The European Society of Cardiology recommends considering high-risk features, such as elevated troponin levels, recurrent ischemia, hemodynamic instability, major arrhythmias, and diabetes mellitus, to require invasive strategy 5
- The European Society of Cardiology suggests that low-risk features, such as normal troponin at presentation and 6-12 hours later, no recurrent chest pain during observation, no ECG changes, and hemodynamically stable, can proceed with stress testing (exercise stress test, stress echocardiography, or coronary CT angiography) before discharge or as outpatient 5
Alternative Diagnoses to Consider
- The American College of Cardiology recommends considering alternative diagnoses, such as cardiovascular syndrome X, gastroesophageal reflux disease, musculoskeletal chest wall pain, acute aortic syndrome, and pulmonary embolism, if cardiac workup is negative or indeterminate 6, 7
- The American College of Cardiology suggests treating cardiovascular syndrome X with nitrates, beta-blockers, and calcium channel blockers 6, 7
- The American College of Cardiology recommends considering acute aortic syndrome, which requires immediate CT angiography, and pulmonary embolism, which requires CT pulmonary angiography 4
Disposition
- The European Society of Cardiology recommends immediate cardiac catheterization laboratory activation for STEMI or high-risk features 5, 1
- The European Society of Cardiology suggests hospital admission for invasive strategy within 24-48 hours for intermediate-risk with positive troponin 5
- The American College of Cardiology recommends treating underlying condition and avoiding empiric cardiac medications for confirmed non-cardiac cause 6